These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 1377002)

  • 21. Gene expression profiling of isogenic cells with different TP53 gene dosage reveals numerous genes that are affected by TP53 dosage and identifies CSPG2 as a direct target of p53.
    Yoon H; Liyanarachchi S; Wright FA; Davuluri R; Lockman JC; de la Chapelle A; Pellegata NS
    Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15632-7. PubMed ID: 12438652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutations of the TP53 gene in adenocarcinoma and squamous cell carcinoma of the cervix: a systematic review.
    Tornesello ML; Buonaguro L; Buonaguro FM
    Gynecol Oncol; 2013 Mar; 128(3):442-8. PubMed ID: 23168175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutagenesis of the H-ras protooncogene and the p53 tumor suppressor gene.
    Cerutti P; Hussain P; Pourzand C; Aguilar F
    Cancer Res; 1994 Apr; 54(7 Suppl):1934s-1938s. PubMed ID: 7907948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutation of tumor suppressor gene p53 is frequently found in vulvar carcinoma cells.
    Hietanen SH; Kurvinen K; Syrjänen K; Grénman S; Carey T; McClatchey K; Syrjänen S
    Am J Obstet Gynecol; 1995 Nov; 173(5):1477-82. PubMed ID: 7503188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TP53 mutational pattern in Spanish and Polish non-small cell lung cancer patients: null mutations are associated with poor prognosis.
    de Anta JM; Jassem E; Rosell R; Martínez-Roca M; Jassem J; Martínez-López E; Monzó M; Sánchez-Hernández JJ; Moreno I; Sánchez-Céspedes M
    Oncogene; 1997 Dec; 15(24):2951-8. PubMed ID: 9416838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinct pattern of TP53 mutations in squamous cell carcinoma of the esophagus in Iran.
    Sepehr A; Tanière P; Martel-Planche G; Zia'ee AA; Rastgar-Jazii F; Yazdanbod M; Etemad-Moghadam G; Kamangar F; Saidi F; Hainaut P
    Oncogene; 2001 Nov; 20(50):7368-74. PubMed ID: 11704866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Significance of TP53 mutations in human cancer: a critical analysis of mutations at CpG dinucleotides.
    Soussi T; Béroud C
    Hum Mutat; 2003 Mar; 21(3):192-200. PubMed ID: 12619105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p53 alterations in plutonium-induced F344 rat lung tumors.
    Kelly G; Stegelmeier BL; Hahn FF
    Radiat Res; 1995 Jun; 142(3):263-9. PubMed ID: 7761575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Codon 249 of the human TP53 tumor suppressor gene is no hot spot for aflatoxin B1 in a heterologous background.
    Sengstag C; Mörbe JL; Weibel B
    Mutat Res; 1999 Nov; 430(1):131-44. PubMed ID: 10592324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Somatic TP53 Mutations in the Era of Genome Sequencing.
    Hainaut P; Pfeifer GP
    Cold Spring Harb Perspect Med; 2016 Nov; 6(11):. PubMed ID: 27503997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p53 gene mutations in primary lung tumors are conserved in brain metastases.
    Schlegel U; Rosenfeld MR; Volkenandt M; Rosenblum M; Dalmau J; Furneaux H
    J Neurooncol; 1992 Oct; 14(2):93-100. PubMed ID: 1331352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High frequency and heterogeneous distribution of p53 mutations in aflatoxin B1-induced mouse lung tumors.
    Tam AS; Foley JF; Devereux TR; Maronpot RR; Massey TE
    Cancer Res; 1999 Aug; 59(15):3634-40. PubMed ID: 10446974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterisation of molecular alterations in microdissected archival gliomas.
    Walker C; Joyce KA; Thompson-Hehir J; Davies MP; Gibbs FE; Halliwell N; Lloyd BH; Machell Y; Roebuck MM; Salisbury J; Sibson DR; Du Plessis D; Broome J; Rossi ML
    Acta Neuropathol; 2001 Apr; 101(4):321-33. PubMed ID: 11355303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group.
    Chiba I; Takahashi T; Nau MM; D'Amico D; Curiel DT; Mitsudomi T; Buchhagen DL; Carbone D; Piantadosi S; Koga H
    Oncogene; 1990 Oct; 5(10):1603-10. PubMed ID: 1979160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutation and expression of TP53 in malignant melanomas.
    Weiss J; Heine M; Arden KC; Körner B; Pilch H; Herbst RA; Jung EG
    Recent Results Cancer Res; 1995; 139():137-54. PubMed ID: 7597286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutational spectra of human cancer.
    Pfeifer GP; Besaratinia A
    Hum Genet; 2009 Jun; 125(5-6):493-506. PubMed ID: 19308457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TP53 mutations in astrocytic gliomas: an association with histological grade, TP53 codon 72 polymorphism and p53 expression.
    Faria MH; Neves Filho EH; Alves MK; Burbano RM; de Moraes Filho MO; Rabenhorst SH
    APMIS; 2012 Nov; 120(11):882-9. PubMed ID: 23009112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TP53 gene in blood plasma DNA of tumor patients.
    Schlechte HH; Stelzer C; Weickmann S; Fleischhacker M; Schulze G
    Ann N Y Acad Sci; 2004 Jun; 1022():61-9. PubMed ID: 15251941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Profiling of Germline Mutations in Major Hotspot Codons of TP53 Using PCR-RFLP.
    Srividya ; Giridhar BH; Vishwanath S; Chakraborty A
    Pathol Oncol Res; 2019 Oct; 25(4):1373-1377. PubMed ID: 29500733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rat p53 gene mutations in primary Zymbal gland tumors induced by 2-amino-3-methylimidazo[4,5-f]quinoline, a food mutagen.
    Makino H; Ishizaka Y; Tsujimoto A; Nakamura T; Onda M; Sugimura T; Nagao M
    Proc Natl Acad Sci U S A; 1992 Jun; 89(11):4850-4. PubMed ID: 1594584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.